Balyasny Asset Management’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,479
Closed -$118K 3037
2023
Q3
$118K Buy
+11,479
New +$109K ﹤0.01% 2108
2021
Q2
Sell
-7,597
Closed -$350K 2483
2021
Q1
$350K Sell
7,597
-1,818
-19% -$86.8K ﹤0.01% 1473
2020
Q4
$403K Sell
9,415
-17,074
-64% -$648K ﹤0.01% 1151
2020
Q3
$1.08M Buy
26,489
+17,505
+195% +$872K 0.01% 975
2020
Q2
$492K Sell
8,984
-952
-10% -$54.5K ﹤0.01% 928
2020
Q1
$520K Buy
+9,936
New +$538K 0.01% 898

Other funds holding TRHC

Balyasny Asset Management's TRHC Position: Q4 2023 in Review

Balyasny Asset Management sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 11,479 shares — an estimated $118K sold.

Balyasny Asset Management first reported a position in TRHC in Q1 2020 and held it in 6 quarters. The position peaked at $1.08M in Q3 2020. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.

  • Balyasny Asset Management reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 11,479 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $118K.
  • Balyasny Asset Management first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q1 2020 and held it in 6 quarters.
  • Balyasny Asset Management's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $1.08M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.

Based on Balyasny Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.